Rahul Adakmol has been appointed as the Chief Executive Officer of Bliss GVS Pharma Ltd., following the approval of the Company’s Board of Directors. In his new role, he will lead the company’s next phase of growth by strengthening its global presence, expanding strategic partnerships, accelerating innovation and driving operational excellence.
Rahul brings over two decades of leadership experience across the pharmaceutical and healthcare sectors, with expertise spanning sales, marketing, manufacturing, supply chain, strategy, licensing, M&A, portfolio management, R&D and international operations. Prior to joining Bliss GVS Pharma, he served as Chief Operating Officer – International Operations at Bharat Serums and Vaccines Limited (BSV), where he built a USD 100+ million specialty business, drove global expansion across 70+ countries, and played a key role in business transformation and value creation.
Earlier, Rahul spent over 15 years at Dr. Reddy’s Laboratories, holding senior leadership roles across business development, portfolio strategy, M&A and corporate planning, where he led major acquisitions, licensing partnerships and strategic growth initiatives. He began his career with Reliance Industries Limited, building a strong foundation in strategic and operational leadership.
Rahul’s appointment reflects his proven ability to deliver sustainable growth, build high-performing teams and drive business transformation, positioning Bliss GVS Pharma for continued success in the global pharmaceutical industry.